In an era where algorithmic hypothesis generation outpaces experimental validation capacity, the Centre of Excellence positions Arctoris at the critical interface between computational design and empirical truth
Neurological disorder research is evolving from single cells to complex networks thanks to 3D brain cultures and multielectrode arrays
Three therapeutic targets selected across high‑value clinical indications pipeline planned for four radiotherapy assets with in vivo data expected by end of 2026
Michael Richardson explains how Inotiv is unlocking new insights into disease mechanisms and therapeutic effectiveness using spatial transcriptomics, proteomics, and AI-powered image analytics.
Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery
This guest editorial explores how emerging AI tools are significantly enhancing the utility of flow cytometry across life sciences and highlights how industry leaders must work together to overcome challenges
Scientists at the University of Edinburgh engineered E. coli bacteria to turn a type of plastic used widely in food and drink packaging – polyethylene terephthalate, or PET – into L-DOPA
Phesi founder, Dr. Gen Li, shares how patient-centric data science and AI are set to transform global healthcare outcomes in cancer
Cast your vote today for the chance to win a $100 Amazon Gift Card
Leadership team is strengthened to support next phase of growth as organization evolves to meet needs of global drug discovery community
Cutting-edge technologies and collaborative research are transforming how scientists overcome genomic instability and accelerate therapeutic protein production
Jiahui International Cancer Center (JICC) stabilized non‑small cell lung cancer (NSCLC) and Parkinson's disease in patient using novel immunotherapy ivonescimab
By adopting Simplicis Ledger™, Flare Therapeutics replaces manual 'human-babysitting' of data with automation-ready infrastructure to scale life sciences R&D
ExPERT DTx streamlines workflows by processing up to 96 samples in a single, three-minute run
Industry leaders outlined how artificial intelligence, digital lab orchestration, and scalable automation will transform scientific discovery and operational resilience in 2026 and beyond
This assay uses hiPSC‑derived cardiomyocytes with Maestro MEA technology to measure electrophysiology across a functional cardiac syncytium
Bioxytran’s drug candidate, PHM23, utilizes a novel mechanism of action that targets galectin proteins critical to viral replication
A breakthrough approach that overcomes scale-up and consistency challenges in microsphere production
In this SelectScience interview, discover why AI in clinical data management must prioritize transparency, traceability, and reproducibility to earn trust in regulated environments
Strategic data collaboration will allow pharmaceutical and biotech companies to connect real-world data with clinical research
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery
VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
Tahoe Therapeutics aims to use the speed and accuracy of these automated systems to generate a dataset fifty times larger than its already record-breaking Tahoe 100 million single-cell atlas
A computer simulation technique known as molecular dynamics will be used to study how G-protein-coupled receptors interact with the intracellular effector inside the cell
EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights
